Progyny(PGNY)
$36.50+0.07 (+0.19%)
PGNY
Progyny financials statements
$36.50
At close:+0.07 (+0.19%)
Want to see PGNY full AI Analyst Report?
Progyny (PGNY) Ratios
710 Followers
Progyny Ratios
PGNY's free cash flow for Q3 2026 was $47.24M. For the 2026 fiscal year, PGNY's free cash flow was decreased by $-9.37M and operating cash flow was $56.60M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.73 | 2.80 | 3.44 | 2.72 | 2.62 |
| Quick Ratio | 2.73 | 2.80 | 3.44 | 2.72 | 2.62 |
| Cash Ratio | 0.55 | 0.96 | 0.52 | 0.75 | 0.93 |
| Solvency Ratio | 0.28 | 0.31 | 0.32 | 0.19 | 0.63 |
| Operating Cash Flow Ratio | 1.04 | 1.06 | 1.02 | 0.50 | 0.26 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 325.38M | $ 287.68M | $ 437.22M | $ 267.84M | $ 152.30M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.03 | 0.03 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.05 | 0.05 | 0.04 | 0.02 | 0.03 |
| Debt-to-Capital Ratio | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.44 | 1.44 | 1.37 | 1.44 | 1.42 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.33 | 0.21 | 0.20 | 0.08 | 0.10 |
| Net Debt to EBITDA | -0.84 | -1.66 | -1.21 | -4.51 | -2.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 23.63% | 21.71% | 21.94% | 21.26% | 22.40% |
| EBIT Margin | 7.41% | 7.13% | 5.71% | 2.97% | 6.46% |
| EBITDA Margin | 7.79% | 7.40% | 5.92% | 3.17% | 6.72% |
| Operating Profit Margin | 6.62% | 5.78% | 5.71% | 2.97% | 6.46% |
| Pretax Profit Margin | 7.41% | 7.13% | 6.49% | 3.11% | 6.48% |
| Net Profit Margin | 4.54% | 4.66% | 5.70% | 3.86% | 13.14% |
| Continuous Operations Profit Margin | 4.54% | 4.66% | 5.70% | 3.86% | 13.14% |
| Net Income Per EBT | 61.32% | 65.31% | 87.76% | 124.21% | 202.77% |
| EBT Per EBIT | 111.91% | 123.34% | 113.68% | 104.71% | 100.29% |
| Return on Assets (ROA) | 7.88% | 8.95% | 8.20% | 5.59% | 18.37% |
| Return on Equity (ROE) | 11.34% | 12.87% | 11.21% | 8.05% | 26.12% |
| Return on Capital Employed (ROCE) | 15.79% | 15.38% | 10.90% | 6.09% | 12.47% |
| Return on Invested Capital (ROIC) | 9.62% | 9.98% | 9.53% | 6.07% | 12.42% |
| Return on Tangible Assets | 8.17% | 9.21% | 8.33% | 5.72% | 19.03% |
| Earnings Yield | 2.67% | 3.44% | 1.76% | 1.06% | 1.47% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.85 | 4.96 | 4.50 | 3.28 | 3.72 |
| Payables Turnover | 7.93 | 9.61 | 6.78 | 5.67 | 6.33 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 23.47 | 39.39 | 39.13 | 51.52 | 39.01 |
| Asset Turnover | 1.74 | 1.92 | 1.44 | 1.45 | 1.40 |
| Working Capital Turnover Ratio | 3.94 | 3.08 | 2.99 | 3.63 | 3.68 |
| Cash Conversion Cycle | 16.38 | 35.61 | 27.23 | 46.97 | 40.42 |
| Days of Sales Outstanding | 62.39 | 73.59 | 81.10 | 111.35 | 98.10 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 46.01 | 37.98 | 53.87 | 64.38 | 57.69 |
| Operating Cycle | 62.39 | 73.59 | 81.10 | 111.35 | 98.10 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.47 | 1.96 | 1.99 | 0.87 | 0.29 |
| Free Cash Flow Per Share | 2.25 | 1.90 | 1.95 | 0.84 | 0.27 |
| Dividend Paid and CapEx Coverage Ratio | 11.42 | 33.14 | 51.82 | 24.81 | 12.23 |
| Capital Expenditure Coverage Ratio | 11.42 | 33.14 | 51.82 | 24.81 | 12.23 |
| Operating Cash Flow Coverage Ratio | 7.58 | 9.29 | 9.74 | 10.42 | 3.01 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.15 | 0.17 | 0.10 | 0.05 |
| Free Cash Flow Yield | 8.76% | 11.01% | 5.24% | 2.69% | 0.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 37.76 | 29.24 | 56.95 | 94.60 | 68.22 |
| Price-to-Sales (P/S) Ratio | 1.70 | 1.35 | 3.25 | 3.65 | 8.96 |
| Price-to-Book (P/B) Ratio | 4.24 | 3.74 | 6.38 | 7.62 | 17.82 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.41 | 9.08 | 19.08 | 37.22 | 187.66 |
| Price-to-Operating Cash Flow Ratio | 10.41 | 8.81 | 18.71 | 35.72 | 172.31 |
| Price-to-Earnings Growth (PEG) Ratio | 2.48 | -3.17 | 0.59 | -1.71 | 1.84 |
| Enterprise Value Multiple | 20.96 | 16.61 | 53.59 | 110.64 | 130.90 |
| Enterprise Value | 2.10B | 1.44B | 3.45B | 2.76B | 4.40B |
| EV to EBITDA | 20.96 | 16.61 | 53.59 | 110.64 | 130.90 |
| EV to Sales | 1.63 | 1.23 | 3.17 | 3.51 | 8.80 |
| EV to Free Cash Flow | 10.97 | 8.26 | 18.66 | 35.77 | 184.19 |
| EV to Operating Cash Flow | 10.01 | 8.01 | 18.30 | 34.32 | 169.13 |
| Tangible Book Value Per Share | 5.75 | 4.43 | 5.70 | 3.96 | 2.69 |
| Shareholders’ Equity Per Share | 6.05 | 4.61 | 5.82 | 4.09 | 2.83 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.39 | 0.35 | 0.12 | -0.24 | -1.03 |
| Revenue Per Share | 15.12 | 12.76 | 11.46 | 8.54 | 5.62 |
| Net Income Per Share | 0.69 | 0.59 | 0.65 | 0.33 | 0.74 |
| Tax Burden | 0.61 | 0.65 | 0.88 | 1.24 | 2.03 |
| Interest Burden | 1.00 | 1.00 | 1.14 | 1.05 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.17 | 0.16 | 0.11 | 0.12 | 0.12 |
| Stock-Based Compensation to Revenue | 0.10 | 0.11 | 0.11 | 0.13 | 0.00 |
| Income Quality | 3.59 | 3.30 | 3.04 | 2.65 | 0.40 |
Currency in USD
